Murota M - Search Results

1

Aldehyde dehydrogenase-2 genotypes and HLA haplotypes in Japanese patients with esophageal cancer.

Watanabe S, Sasahara K, Kinekawa F, Uchida N, Masaki T, Kurokohchi K, Murota M, Touge T, Kawauchi K, Oda S, Kuriyama S. Watanabe S, et al. Among authors: murota m. Oncol Rep. 2002 Sep-Oct;9(5):1063-8. Oncol Rep. 2002. PMID: 12168074

2

Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.

Yoshida S, Kurokohchi K, Arima K, Masaki T, Hosomi N, Funaki T, Murota M, Kita Y, Watanabe S, Kuriyama S. Yoshida S, et al. Among authors: murota m. Int J Oncol. 2002 Feb;20(2):305-9. Int J Oncol. 2002. PMID: 11788893

3

Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat.

Kurokohchi K, Watanabe S, Masaki T, Hosomi N, Funaki T, Arima K, Yoshida S, Nakai S, Murota M, Miyauchi Y, Kuriyama S. Kurokohchi K, et al. Among authors: murota m. Int J Oncol. 2002 Sep;21(3):611-5. Int J Oncol. 2002. PMID: 12168107 Clinical Trial.

4

Aberrant cytokeratin expression and high susceptibility to apoptosis in autoimmune hepatitis.

Murota M, Watanabe S, Fujita J, Ohtsuki Y, Wu F, Yoshida S, Kita Y, Funakoshi F, Masaki T, Kurokohchi K, Uchida N, Ishida T, Kuriyama S. Murota M, et al. Hepatol Res. 2003 Mar;25(3):271-280. doi: 10.1016/s1386-6346(02)00277-2. Hepatol Res. 2003. PMID: 12697248

5

Autoreactive helper T cells specific for cytokeratin 19 in patients with autoimmune hepatitis.

Morishita A, Murota M, Fujita J, Wu F, Kurokohchi K, Masaki T, Arima K, Watanabe S, Kuriyama S. Morishita A, et al. Among authors: murota m. Hepatol Res. 2003 Apr;25(4):415-422. doi: 10.1016/s1386-6346(02)00314-5. Hepatol Res. 2003. PMID: 12699852

6

Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.

Mohammad HS, Kurokohchi K, Yoneyama H, Tokuda M, Morishita A, Jian G, Shi L, Murota M, Tani J, Kato K, Miyoshi H, Deguchi A, Himoto T, Usuki H, Wakabayashi H, Izuishi K, Suzuki Y, Iwama H, Deguchi K, Uchida N, Sabet EA, Arafa UA, Hassan AT, El-Sayed AA, Masaki T. Mohammad HS, et al. Among authors: murota m. Int J Oncol. 2008 Dec;33(6):1157-63. Int J Oncol. 2008. PMID: 19020748

7

Use of protein array to investigate receptor tyrosine kinases activated in gastric cancer.

Gong J, Morishita A, Kurokohchi K, Tani J, Kato K, Miyoshi H, Inoue H, Kobayashi M, Liu S, Murota M, Muramatsu A, Izuishi K, Suzuki Y, Yoshida H, Uchida N, Deguchi K, Iwama H, Ishimaru I, Masaki T. Gong J, et al. Among authors: murota m. Int J Oncol. 2010 Jan;36(1):101-6. Int J Oncol. 2010. PMID: 19956838

8

Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.

Wu F, Nishioka M, Fujita J, Murota M, Ohtsuki Y, Ishida T, Kuriyama S. Wu F, et al. Among authors: murota m. Int J Oncol. 2002 Jan;20(1):31-7. Int J Oncol. 2002. PMID: 11743639

9

CYFRA 21-1 is released in TNF-alpha-induced apoptosis in the hepatocellular carcinoma cell line HuH-7.

Wu F, Fujita J, Murota M, Li JQ, Ishida T, Nishioka M, Imaida Y, Kuriyama S. Wu F, et al. Among authors: murota m. Int J Oncol. 2002 Aug;21(2):441-5. Int J Oncol. 2002. PMID: 12118343

10

Clinical characteristics of patients with autoimmune hepatitis seropositive for anticentromere antibody.

Himoto T, Murota M, Yoneyama H, Deguchi A, Kurokochi K, Senda S, Haba R, Watanabe S, Nishioka M, Masaki T. Himoto T, et al. Among authors: murota m. Hepatol Res. 2010 Aug;40(8):786-92. doi: 10.1111/j.1872-034X.2010.00684.x. Hepatol Res. 2010. PMID: 20649818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters